Rhonda Farnum insider trades
Open-market stock purchases and sales by Rhonda Farnum, SVP, COMM & MEDICAL AFFAIRS at Theravance Biopharma, Inc, from SEC Form 4 filings since Dec 14, 2021.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc | Sold (not open market) | — |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc | Sold (not open market) | — |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc | Sold (not open market) | $3.8M |
| Sep 15, 2026 | TBPH Theravance Biopharma, Inc | Sold | $56.7K |
| Sep 15, 2026 | TBPH Theravance Biopharma, Inc | Sold | $56.7K |
| Sep 15, 2026 | TBPH Theravance Biopharma, Inc | Sold | $113K |
| Aug 20, 2026 | TBPH Theravance Biopharma, Inc | Sold (not open market) | $96.1K |
| Jun 15, 2026 | TBPH Theravance Biopharma, Inc | Sold | $54.6K |
| Jun 15, 2026 | TBPH Theravance Biopharma, Inc | Sold | $54.5K |
| Jun 15, 2026 | TBPH Theravance Biopharma, Inc | Sold | $109K |
| May 20, 2026 | TBPH Theravance Biopharma, Inc | Sold (not open market) | $94K |
| Apr 1, 2026 | TBPH Theravance Biopharma, Inc | Bought (not open market) | — |
| Mar 16, 2026 | TBPH Theravance Biopharma, Inc | Sold | $108K |
| Mar 16, 2026 | TBPH Theravance Biopharma, Inc | Sold | $217K |
| Mar 16, 2026 | TBPH Theravance Biopharma, Inc | Sold | $108K |
| Feb 20, 2026 | TBPH Theravance Biopharma, Inc | Sold (not open market) | $274K |
| Dec 3, 2025 | TBPH Theravance Biopharma, Inc | Sold | $146K |
| Dec 3, 2025 | TBPH Theravance Biopharma, Inc | Sold | $146K |
| Dec 3, 2025 | TBPH Theravance Biopharma, Inc | Sold | $291K |
| Nov 20, 2025 | TBPH Theravance Biopharma, Inc | Sold (not open market) | $162K |
Companies traded
- TBPH Theravance Biopharma, Inc: 27 sales, last Sep 23, 2026